Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027
Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin (DWN12088), its first-in-class...
Search results for "poster"
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual Meeting and present poster data...
Struggles with Shirt Buttons? It Could Be 'Cervical Myelopathy,' a Condition Often Missed in Seniors
Cervical myelopathy, unlike conditions such as a cervical herniated disc that compresses a nerve root on one side,...
From a Minor Fender Bender to Paralysis? The Hidden Danger of OPLL
Mr. A, a 50-year-old office worker from Busan, had lived with a stiff neck and tingling fingertips for years.
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year
The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
Kyungpook National University Hospital Team Wins Back-to-Back Awards at International Congress
A research team led by Professor Yoon Jong-pil of the Department of Orthopedic Surgery at Kyungpook National University...
Can AI Spot At-Risk Patients Early? Hospitals Explore the Next Frontier
Can artificial intelligence detect warning signs before a patient's condition becomes critical.
Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026
Samsung Biologics has unveiled a process innovation case study demonstrating a reduction in biopharmaceutical...
Ophthalmologists Declare Myopia a Structural Disease as Complication Risks Soar
Is myopia management complete once a new pair of glasses restores crisp, clear vision.
Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral...